Dr. Li-Meng Yan Claims the J&J blood Cancer drug DARZALEX is the antidote

Dr. Li-Meng Yan Claims the J&J blood cancer drug DARZALEX (daratumumab) is the antidote for the hemorrhagic fever virus

https://www.jnj.com/media-center/press-releases/darzalex-daratumumab-approved-by-us-fda-first-human-anti-cd38-monoclonal-antibody-available-for-the-treatment-of-multiple-myeloma